A practical approach to persistent elevation of blood pressure in the hypertension clinic

Blood Pressure Monitoring

Volumn 8, Issue 3, 2003, Pages 97-100

  Mansoor, George A ^a  

^a Sect Hypertension/Clin Pharmacol   (United States)

Author keywords

Hypertension; Pseudohypertension; Resistant hypertension; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; EPHEDRA EXTRACT; HYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CUFF; HUMAN; HYPERTENSION; LIFESTYLE; OUTPATIENT DEPARTMENT; PHEOCHROMOCYTOMA; PLETHYSMOGRAPHY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PSEUDOHYPERTENSION; RENOVASCULAR HYPERTENSION; SLEEP APNEA SYNDROME; WHITE COAT HYPERTENSION;

EID: 0042383311     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200306000-00001     Document Type: Article

References (26)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 21(289):2560-2571.
2. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162:1051-1058.
3. Spence JD. Pseudohypertension in the elderly: still hazy, after all these years. J Hum Hypertens 1997; 10:621-623.
4. Rosner MH, Okusa MD. Pseudohypertension in a patient with diffuse scleroderma. Am J Kidney Dis 2001; 4:E32.
5. Bastianon V. Pseudohypertension and Williams syndrome. Pediatr Cardiol 1996; 17:132.
6. Kuriyama S, Tomonari H, Utsunomiya Y, Kinoshita N, Matsumoto H. Pseudohypertension in hemodialyzed arteriosclerotic patients. Nephron 1994; 66:479-480.
7. Oliner CM, Elliott WJ, Gretler DD, Murphy MB. Low predictive value of positive Osler's maneuver for diagnosing pseudohypertension. J Hum Hypertens 1993; 1:65-70.
8. Hla KM, Samsa GP, Stoneking HT, Feussner JR. Observer variability of Osler's maneuver in detection of pseudohypertension. J Clin Epidemiol 1991; 44:513-518.
9. Vidyasagar S, Dwivedi S. Pseudohypertension with calcific aortic stenosis and angina pectoris. J Assoc Physicians India 1989; 37:229-230.
10. Sprague DH, Kim DI. Pseudohypertension due to Monckeberg's arteriosclerosis. Anesth Analg 1978; 57:588-589.
11. Wright JC, Looney SW. Prevalence of positive Osler's maneuver in 3387 persons screened for the Systolic Hypertension in the Elderly Program (SHEP). J Hum Hypertens 1997; 5:285-289.
12. Anzal M, Palmer AJ, Starr J, Bulpitt CJ. The prevalence of pseudohypertension in the elderly. J Hum Hypertens 1996; 10:409-411.
13. Myers MG, Reeves RA. White coat phenomenon in patients receiving anti-hypertensive therapy. Am J Hypertens 1991; 10:844-849.
14. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001; 12:1263-1269.
15. Le Pailleur C, Helft G, Landais P, Montgermont P, Feder JM, Metzger JP, et al. The effects of talking, reading, and silence on the 'white coat' phenomenon in hypertensive patients. Am J Hypertens 1998; 2:203-207.
16. Mejia AD, Egan BM, Schork NJ, Zweifler AJ. Artifacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med 1990; 112:270-277.
17. Mansoor GA, White WB. Clinician's corner. Blood Press Monit 1996; 1:75-79.
18. Mezzetti A, Pierdomenico SD, Costantini F, Romano F, Bucci A, Di Gioacchino M, et al. White-coat resistant hypertension. Am J Hypertens 1997; 10:1302-1307.
19. Le Pailleur C, Montgermont P, Feder JM, Metzger JP, Vacheron A. Talking effect and 'white coat' effect in hypertensive patients: physical effort or emotional content? Behav Med 2001; 26:149-157.
20. Peters GL, Binder SK, Campbell NR. The effect of crossing legs on blood pressure: a randomized single blind crossover study. Blood Press Monit 1999; 4:97-10.
21. Setaro JF, Black HR. Refractory hypertension. N Engl J Med 1992; 20:327:543-547.
22. Gallay BJ, Ahmad S, Xu L, Toivela B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37:699-705.
23. Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of anti-hypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf) 2002; 57:457-465.
24. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001; 19:2271-2277.
25. Isaksson H, Svanborg E. Obstructive sleep apnea syndrome in male hypertensives refractory, to drug therapy. Nocturnal automatic blood pressure measurements - an aid to diagnosis? Clin Exp Hypertens A 1991; 13:1195-1212.
26. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, et al. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21:241-247.